Immunological Data Discovery Index
Advanced Search
identifier: 1650599
description:
epitope description:HQCHQESTRGRSRGRCGRSGS + CITR(R9)
host organism:Homo sapiens
aggregation:
instance of dataset
availability:
available
primaryPublications: 10943873
authorizations:
registration not required
accessURL: http://www.iedb.org/reference/1015103
landingPage: http://www.iedb.org/assay/1650599
type:
Literature
publicationVenue:
Arthritis Rheum
dates:
2000
study type: b cell assays
subject species:
fullName:
E J Kroot
B A de Jong
M A van Leeuwen
H Swinkels
F H van den Hoogen
M van't Hof
L B van de Putte
M H van Rijswijk
W J van Venrooij
P L van Riel
method:
ELISA
name:
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.
description:
The epitope sequence is reported in Schellekens et al., Arthritis Rheum. 2000 Jan
43(1):155-63. [PMID: 10643712]. Cysteine substitutions were made to facilitate formation of a cyclic peptide.
The responses of recent-onset RA patients to the peptide were determined, and statistical analyses were later performed to quantify the predictive value of these responses for future severity of disease. Patients with anti-CCP had developed significantly more severe radiologic damage after 6 years of follow-up. In multiple regression analysis, radiologic damage after 6 years follow-up was significantly predicted by IgM-RF status, radiologic score at entry, and anti-CCP status. Functional disability was significantly predicted by sex, age at entry, IgM-RF status, and DAS.